Login
Enter your username or email address.

Request new password

Home

Progress in Mind Middle East and Africa

  • Topics
    • COVID-19 Pandemic
    • Alcohol Dependance
    • Alzheimer's Disease
    • Bipolar Disease
    • Depression
    • Schizophrenia
    • Parkinson's Disease
    • Migraine
  • Congress highlights
    • ECNP 2022
    • ASUIP 2022
    • EAN 2022
    • COVID-19 MEA
    • ECNP 2021
    • EAN 2021
    • APA 2019
  • Expert Views
  • Podcast
  • About Us

The information on this site is exclusively intented for health care professionals.

ACCEPT DECLINE
13 Sep, 2020 Read Time: 3 mins

Do long-acting injectable antipsychotics have a role in early-phase schizophrenia?

Sign up for Progress in Mind Middle East and Africa

Sign up for our newsletter and stay updated on new content and resources.

Related

Depression
Article

Does glutamate hold the key to unlocking major depressive disorder?

Schizophrenia
Article

Complementary approaches for improving outcomes in first-episode psychosis

Schizophrenia
Article

Negative symptoms in schizophrenia – get thee gone!

Social Networks

Tags

  • Adherence
  • Course of disease
  • First episode
  • Patient management
  • Relapse
  • Treatment
  • Early-phase schizophrenia

Progress in Mind Middle East and Africa HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in Middle East and Africa click here.

Register Already registered

Brought to you by

 Lundbeck

© 2022 Lundbeck Middle East and Africa

PROGRESS IN MIND MIDDLE EAST & AFRICA

Cookies

Privacy Information and Disclaimer

subscribe newsletter

Sign up for newsletter

Register as a health care professional

Login as a registered health care professional

Please enter your email to continue